We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Itron
ITRI
$4.36B
| $3.96M | 0.01% |
65,280
+17,958
| +38% | +$1.12M |
|
|
ZLTQ
1152
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $3.96M | 0.01% |
71,207
+22,009
| +45% | +$1.1M |
|
|
WMGI
1153
DELISTED
Wright Medical Group Inc
WMGI
| $3.95M | 0.01% |
126,972
+2,523
| +2% | +$68.4K |
|
1154
Kite Realty
KRG
$5.81B
| $3.94M | 0.01% |
183,444
+51,217
| +39% | +$1.16M |
|
|
UCB
1155
United Community Banks
UCB
$4.24B
| $3.94M | 0.01% |
142,237
+38,384
| +37% | +$1.09M |
|
1156
Oil States International
OIS
$488M
| $3.93M | 0.01% |
118,431
+3,386
| +3% | +$124K |
|
|
CCMP
1157
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $3.93M | 0.01% |
51,241
+14,859
| +41% | +$1.02M |
|
|
CORE
1158
DELISTED
Core Mark Holding Co., Inc.
CORE
| $3.92M | 0.01% |
125,781
+46,049
| +58% | +$1.61M |
|
1159
WD-40
WDFC
$3.05B
| $3.91M | 0.01% |
35,870
+9,037
| +34% | +$984K |
|
1160
Spectrum Brands
SPB
$2.04B
| $3.9M | 0.01% |
28,054
+1,064
| +4% | +$141K |
|
|
AVP
1161
DELISTED
Avon Products, Inc.
AVP
| $3.9M | 0.01% |
886,426
+27,732
| +3% | +$138K |
|
|
PFPT
1162
DELISTED
Proofpoint, Inc.
PFPT
| $3.9M | 0.01% |
52,387
+3,498
| +7% | +$278K |
|
|
NSR
1163
DELISTED
Neustar Inc
NSR
| $3.9M | 0.01% |
117,492
-290
| -0.2% | -$9.64K |
|
1164
iShares Russell 2000 ETF
IWM
$79.8B
| $3.89M | 0.01% |
28,290
+5,570
| +25% | +$761K |
|
1165
Copa Holdings
CPA
$5.76B
| $3.88M | 0.01% |
34,602
+1,102
| +3% | +$112K |
|
|
AAT
1166
American Assets Trust
AAT
$1.45B
| $3.88M | 0.01% |
92,735
+26,871
| +41% | +$1.15M |
|
1167
DNOW Inc
DNOW
$2.58B
| $3.87M | 0.01% |
228,116
+5,317
| +2% | +$105K |
|
|
AVNS
1168
DELISTED
Avanos Medical
AVNS
| $3.87M | 0.01% |
101,535
+3,562
| +4% | +$139K |
|
|
INVX
1169
Innovex International
INVX
$1.96B
| $3.86M | 0.01% |
70,837
+3,093
| +5% | +$185K |
|
1170
Carpenter Technology
CRS
$25.8B
| $3.86M | 0.01% |
103,377
+3,059
| +3% | +$119K |
|
1171
Strategy Inc
MSTR
$34.1B
| $3.85M | 0.01% |
204,970
+52,320
| +34% | +$1.01M |
|
1172
KBR
KBR
$4.64B
| $3.84M | 0.01% |
255,514
+9,567
| +4% | +$152K |
|
|
STMP
1173
DELISTED
Stamps.com, Inc.
STMP
| $3.82M | 0.01% |
32,293
+8,754
| +37% | +$1.08M |
|
|
BECN
1174
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.81M | 0.01% |
77,610
+2,315
| +3% | +$107K |
|
|
TPH
1175
DELISTED
Tri Pointe Homes
TPH
| $3.81M | 0.01% |
303,635
+19,451
| +7% | +$239K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.